• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers.

作者信息

Rijnbeek B, de Visser S J, Franson K L, Cohen A F, van Gerven J M A

机构信息

Centre for Human Drug Research, Leiden, The Netherlands.

出版信息

J Psychopharmacol. 2003 Jun;17(2):196-203. doi: 10.1177/0269881103017002008.

DOI:10.1177/0269881103017002008
PMID:12870567
Abstract

The potential use of rapid eye movement (REM) sleep effects as a biomarker for the therapeutic effects of antidepressants in healthy volunteers is reviewed. A literature search was performed to select studies investigating the effects of antidepressants on REM sleep. To assess the specificity of REM sleep effects as a biomarker, the effects of other central nervous system drugs on REM sleep were also investigated. A significant REM sleep reduction was shown for 16 of 21 investigated antidepressants after single-dose (mean reduction 34.1%) and for 11/13 drugs after multiple-dose administration (mean reduction 29.2%). The median increase in REM latency was approximatety 60% after single- or multiple-dose administration. REM sleep effects were linearly normalized to therapeutic doses, by dividing the REM sleep effect by the investigated dose and multiplying by the therapeutic dose. Normalized REM sleep effects were highly variable (range -27.0% to 81.8% for REM sleep; range -17.0% to 266.3% for REM latency) and demonstrated no relationship with relevant pharmacological properties of the investigated drugs. No quantifiable dose-response relationship could be constructed after single and multiple dose administration. REM sleep effects were not specific for antidepressants. Benzodiazepines, for example, caused an average dose normalized REM sleep reduction of 8.7% and a median 8.6% increase of REM latency. This review demonstrates that although REM sleep effects occur with most of the antidepressants, it is by itself of limited value as a biomarker for antidepressant action. The specificity for antidepressants is limited, and it does not show a quantitative dose-response relationship to antidepressant agents. This is at least partly due to the complex relationships between drug pharmacokinetics and the variable time course of REM and other sleep stages throughout the night. Models that take these complex relationships into account may provide more comprehensive and quantifiable results.

摘要

相似文献

1
REM sleep effects as a biomarker for the effects of antidepressants in healthy volunteers.
J Psychopharmacol. 2003 Jun;17(2):196-203. doi: 10.1177/0269881103017002008.
2
Sleep laboratory study on single and repeated dose effects of paroxetine, alprazolam and their combination in healthy young volunteers.帕罗西汀、阿普唑仑及其组合对健康年轻志愿者单次及重复给药效应的睡眠实验室研究。
Neuropsychobiology. 2005;51(3):134-47. doi: 10.1159/000085206. Epub 2005 Apr 18.
3
Translational evaluation of JNJ-18038683, a 5-hydroxytryptamine type 7 receptor antagonist, on rapid eye movement sleep and in major depressive disorder.JNJ-18038683(一种 5-羟色胺 7 受体拮抗剂)在快速眼动睡眠和重性抑郁障碍中的转化评估。
J Pharmacol Exp Ther. 2012 Aug;342(2):429-40. doi: 10.1124/jpet.112.193995. Epub 2012 May 8.
4
REM-suppressing effects of amitriptyline and amitriptyline-N-oxide after acute medication in healthy volunteers: results of two uncontrolled pilot trials.健康志愿者急性用药后阿米替林及N-氧化阿米替林对快速眼动睡眠的抑制作用:两项非对照性预试验结果
Pharmacopsychiatry. 1990 Nov;23(6):253-8. doi: 10.1055/s-2007-1014515.
5
Antidepressants and REM sleep in Wistar-Kyoto and Sprague-Dawley rats.Wistar-Kyoto大鼠和Sprague-Dawley大鼠中的抗抑郁药与快速眼动睡眠
Eur J Pharmacol. 2005 Oct 17;522(1-3):63-71. doi: 10.1016/j.ejphar.2005.08.050. Epub 2005 Oct 11.
6
Antidepressants and sleep: a qualitative review of the literature.抗抑郁药与睡眠:文献的定性综述
Drugs. 2005;65(7):927-47. doi: 10.2165/00003495-200565070-00003.
7
The effects of galantamine and buspirone on sleep structure: Implications for understanding sleep abnormalities in major depression.加兰他敏和丁螺环酮对睡眠结构的影响:对理解重度抑郁症睡眠异常的启示。
J Psychopharmacol. 2015 Oct;29(10):1106-11. doi: 10.1177/0269881115598413. Epub 2015 Aug 10.
8
[Biological models of depression: effect of antidepressants on sleep].[抑郁症的生物学模型:抗抑郁药对睡眠的影响]
Encephale. 1995 Dec;21 Spec No 7:35-40.
9
Antidepressants substantially affect basic REM sleep characteristics in narcolepsy-cataplexy patients.抗抑郁药对发作性睡病-猝倒症患者的快速眼动睡眠基本特征有显著影响。
Neuro Endocrinol Lett. 2015;36(5):430-3.
10
REM sleep homeostasis in the absence of REM sleep: Effects of antidepressants.快速眼动睡眠缺失时的快速眼动睡眠稳态:抗抑郁药的作用
Neuropharmacology. 2016 Sep;108:415-25. doi: 10.1016/j.neuropharm.2016.04.047. Epub 2016 May 2.

引用本文的文献

1
Effect of TAAR1/5-HT agonist SEP-363856 on REM sleep in humans.TAAR1/5-HT 激动剂 SEP-363856 对人类快速眼动睡眠的影响。
Transl Psychiatry. 2021 Apr 20;11(1):228. doi: 10.1038/s41398-021-01331-9.
2
Differentiated effects of the multimodal antidepressant vortioxetine on sleep architecture: Part 2, pharmacological interactions in rodents suggest a role of serotonin-3 receptor antagonism.多模式抗抑郁药伏硫西汀对睡眠结构的差异化作用:第2部分,啮齿动物中的药理相互作用提示5-羟色胺-3受体拮抗作用的作用
J Psychopharmacol. 2015 Oct;29(10):1092-105. doi: 10.1177/0269881115592347. Epub 2015 Jul 14.
3
Ventromedial prefrontal cortex regulates depressive-like behavior and rapid eye movement sleep in the rat.
腹内侧前额叶皮层调节大鼠的抑郁样行为和快速眼动睡眠。
Neuropharmacology. 2014 Nov;86:125-32. doi: 10.1016/j.neuropharm.2014.07.005. Epub 2014 Jul 15.
4
Multimodal antidepressant vortioxetine increases frontal cortical oscillations unlike escitalopram and duloxetine--a quantitative EEG study in rats.多模式抗抑郁药伏硫西汀可增加额叶皮质振荡,与艾司西酞普兰和度洛西汀不同——一项大鼠定量脑电图研究
Br J Pharmacol. 2014 Sep;171(18):4255-72. doi: 10.1111/bph.12782.
5
Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture.新型抗抑郁药及褪黑素激动剂/5-羟色胺2C受体拮抗剂阿戈美拉汀对大鼠睡眠-觉醒周期结构的影响。
Psychopharmacology (Berl). 2009 Jul;205(1):93-106. doi: 10.1007/s00213-009-1519-2. Epub 2009 Apr 16.
6
Mirtazapine induced nightmares in an adult male.米氮平在一名成年男性身上诱发了噩梦。
Br J Clin Pharmacol. 2009 Jan;67(1):135-6. doi: 10.1111/j.1365-2125.2008.03305.x. Epub 2008 Nov 5.
7
Pharmacokinetic and pharmacodynamic data to be derived from early-phase drug development: designing informative human pharmacology studies.从早期药物开发中获取药代动力学和药效学数据:设计信息丰富的人体药理学研究。
Clin Pharmacokinet. 2008;47(6):373-81. doi: 10.2165/00003088-200847060-00002.
8
Mirtazapine-induced nightmares.米氮平引起的噩梦。
Prim Care Companion J Clin Psychiatry. 2006;8(5):311. doi: 10.4088/pcc.v08n0510b.
9
Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects.健康受试者中选择性5-羟色胺再摄取抑制剂(SSRI)效应的生物标志物。
Br J Clin Pharmacol. 2005 May;59(5):495-510. doi: 10.1111/j.1365-2125.2005.02342.x.